Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
Capital Southwest Announces Proposed Convertible Notes Offering
-
Tether Launches Holiday Gift Guide for Cannabis Retailers Across Ontario
-
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
-
Journey Medical Corporation Announces U.S. FDA Approval of Emrosi™ (Minocycline Hydrochloride Extended Release Capsules, 40 mg) for the Treatment of Rosacea
-
AMG Reports Financial and Operating Results for the Third Quarter and Nine Months Ended September 30, 2024
-
Arvinas to Participate in Upcoming Investor Conferences
-
Lifecore Biomedical Appoints Thomas Guldager as Vice President, Operations
-
Corbus Pharmaceuticals Presents New CRB-913 Pre-Clinical Data At Obesity Week 2024
-
Kforce Inc. Announces Participation in the UBS Global Technology and AI Conference
-
Kamada to Present at the Stifel 2024 Healthcare Conference
-
American Lithium Provides Operations Update
-
Hatchet Uranium Corp. Signs Agreements with Skyharbour Resources Ltd. on Five Uranium Projects Located Northeast of the Athabasca Basin, Saskatchewan
-
StorageVault Acquires 2 Stores for $10,500,000
-
Canadian Premium Sand Inc. Provides Operational Update and Announces Plans for a US Facility
-
Alta Equipment Group Announces Common Stock Dividend
-
L’Ordre des CPA du Québec, CPA Ontario, and CPA Canada Reach Agreement on Standard Setting and Education
-
Dianthus Therapeutics to Participate in Three Upcoming Healthcare Investor Conferences
-
BioCryst Reports Third Quarter 2024 Financial Results and Provides Business Update
-
TG Therapeutics Reports Third Quarter 2024 Financial Results and Raises BRIUMVI® (ublituximab-xiiy) Full Year Revenue Guidance
-
Opthea to Participate in November Investor Conferences
-
Skye Bioscience Demonstrates Prominent Role of Peripheral CB1 Inhibition and Achieves Significant Weight Loss with Novel CB1-inhibiting Antibody, Nimacimab, in Preclinical Model
-
Tonix Pharmaceuticals Announces Research Agreement with Kenya Medical Research Institute (KEMRI) to Design, Plan and Seek Regulatory Approval for a Phase I Clinical Study of TNX-801 for Mpox in Kenya
-
Sono-Tek Announces Share Buyback
-
EyePoint Pharmaceuticals Announces Participation at Upcoming Investor Conferences
-
Better Choice Company to Host Third Quarter 2024 Financial Results Conference Call on November 12th at 4:30 p.m. ET
-
CytoSorbents Submits Health Canada Medical Device License Application for DrugSorb-ATR Following MDSAP Certification
-
Village Farms International Selected to Testify at Marijuana Rescheduling Hearing
-
Ascendis Pharma and Novo Nordisk Sign Collaboration for Development and Commercialization of TransCon Technology-based Products in Metabolic and Cardiovascular Diseases
-
Treace Enters High Volume Osteotomy Market with Nanoplasty™ 3D Minimally Invasive Bunion Correction™ Procedure
-
Coda Octopus Group Announces Acquisition of Precision Acoustics Limited
-
Colliers named one of Forbes’ World’s Best Employers 2024
-
Fractyl Health Presented New Analysis from Pooled Data of Revita® Clinical Studies Demonstrating Durable Weight Loss Maintenance for One Year at ObesityWeek® 2024
-
Telesat Signs US$39 Million Contract with SatixFy to Develop and Deliver Landing Station Baseband Units for Telesat Lightspeed Network
-
OTC Markets Group Welcomes Corero Network Security plc to OTCQX
-
Cullinan Therapeutics to Present Preclinical Data for CLN-978, a CD19-directed T Cell Engager, at ACR Convergence 2024
-
Rapport Therapeutics to Present at Stifel Healthcare Conference and Jefferies London Healthcare Conference in November
-
Century Therapeutics to Present at Guggenheim’s Inaugural Healthcare Innovation Conference
-
Oruka Therapeutics to Present at Multiple November Investor Conferences
-
IGM Biosciences to Present at Three Upcoming Investor Conferences
-
Memo Therapeutics AG Appoints Frits van Alphen, MD as Chief Development Officer
-
European Medicines Agency Confirms Acceptance of Marketing Authorization Application for AVT05, a Proposed Biosimilar to Simponi® (golimumab)
-
Liquidity Services Announces Fourth Quarter Fiscal Year 2024 Earnings Conference Call
-
Profound Medical Announces TULSA Reimbursement Raised to Urology APC Level 7 Under CMS Outpatient Prospective Payment System (OPPS) Final Rule for CY2025
-
Castellum, Inc. Announces $11.6 Million Higher Sequential Revenue and Gross Profits for Q3 2024
-
Brookfield Asset Management Announces Record Third Quarter Results
-
Aroma Retail Supports Exponential Ecommerce Growth with Descartes Parcel Shipping Solution
-
Descartes Sets Date to Announce Third Quarter Fiscal 2025 Financial Results
-
TD LAWSUIT ALERT: A Securities Fraud Class Action has been filed against TD Bank; Investors are Urged to Contact the Firm by December 23 (NYSE:TD)
-
INVITATION TO DFDS Q3 2024 CONFERENCE CALL
-
BioNTech Announces Third Quarter 2024 Financial Results and Corporate Update


